| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10961957 | Tuberculosis | 2015 | 12 Pages |
Abstract
While quantitative IGRA responses generally fall during treatment for TB, the large degree of variation in results between participants in each study means that IGRAs are unlikely to be useful for monitoring anti-tuberculous treatment in clinical practice for any individual patient.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Vanessa Clifford, Yu He, Christel Zufferey, Tom Connell, Nigel Curtis,